Rafferty Asset Management Llc sold 7,652 shares as Celgene Corp (CELG)'s stock declined 3.49%. The hedge fund run by Sandy Nairn held 270,105 shares of the major pharmaceuticals company at the end of 2017Q3, valued at $39.38 million, down from 296,304 at the end of the previous reported quarter. Mitchell Capital Management Co who had been investing in Gartner Inc for a number of months, seems to be less bullish one the $11.80B market cap company. Polen Capital Management LLC now owns 5,082,991 shares of the biopharmaceutical company's stock valued at $660,128,000 after acquiring an additional 363,108 shares in the last quarter. Inc. boosted its position in shares of Celgene by 5.9% during the second quarter.
Celgene Corporation (NASDAQ:CELG) last issued its earnings results on Thursday, January 26th. It has outperformed by 0.30% the S&P500.
Paradice Investment Management Llc increased its stake in Eros Intl Plc (EROS) by 2.29% based on its latest 2017Q3 regulatory filing with the SEC. The institutional investor held 346,175 shares of the technology company at the end of 2017Q3, valued at $2.66 million, up from 229,155 at the end of the previous reported quarter. The stock increased 1.27% or $0.25 during the last trading session, reaching $19.94. About 766,151 shares traded. The Southern Company (NYSE:SO) has risen 2.49% since January 13, 2017 and is uptrending. It has outperformed by 19.67% the S&P500.
Since August 2, 2017, it had 0 buys, and 5 insider sales for $6.27 million activity. Spinnaker Trust now owns 15,593 shares of the biopharmaceutical company's stock worth $1,940,000 after purchasing an additional 4,411 shares during the period. On Thursday, August 10 the insider MARIO ERNEST sold $2.42 million. On Tuesday, September 5 the insider CASEY MICHAEL D sold $1.29 million.
Smith & Howard Wealth Management Llc, which manages about $511.16 million and $210.66 million US Long portfolio, upped its stake in Ishares Inc (IEMG) by 6,911 shares to 22,680 shares, valued at $1.23M in 2017Q3, according to the filing. It also reduced its holding in Teva Pharmaceutcl Inds Adr (Call) (NYSE:TEVA) by 93,505 shares in the quarter, leaving it with 13,000 shares, and cut its stake in Teva Pharmaceutcl Inds Adr (NYSE:TEVA).
Investors sentiment increased to 1.39 in Q3 2017.
Several large investors have recently added to or reduced their stakes in CELG. 133 funds opened positions while 451 raised stakes. Macquarie Grp Ltd holds 1.30 million shares or 0.05% of its portfolio. Virginia Retirement Et Al holds 0.51% or 288,600 shares in its portfolio. During the same quarter in the previous year, the business earned $1.58 earnings per share. analysts expect that Celgene will post 6.69 EPS for the current year. (NASDAQ:CELG) by 0.9% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. (NYSE:EGHT). Zurcher Kantonalbank (Zurich Cantonalbank) accumulated 2,493 shares or 0% of the stock. Buckingham Cap Mngmt Incorporated invested in 20,045 shares or 0.65% of the stock. American International Group Inc. now owns 348,641 shares of the biopharmaceutical company's stock worth $43,381,000 after buying an additional 1,476 shares during the last quarter. Vident Investment Advisory Ltd Liability Co has invested 0.02% in Celgene Corporation (NASDAQ:CELG). The Tennessee-based Patten & Patten Tn has invested 0.62% in Celgene Corporation (NASDAQ:CELG). The Pennsylvania-based Haverford Trust Communication has invested 0.01% in Celgene Corporation (NASDAQ:CELG). Qs Limited Liability Corporation reported 182,640 shares. Pacific Ridge Cap Prtnrs Lc stated it has 64,040 shares. Moreover, Cetera Advsrs Limited Company has 0.21% invested in Celgene Corporation (NASDAQ:CELG). One investment analyst has rated the stock with a sell rating, fourteen have given a hold rating and nineteen have given a buy rating to the stock. Therefore 75% are positive. Vetr raised Celgene from a "buy" rating to a "strong-buy" rating and set a $144.39 target price on the stock in a research report on Monday, October 23rd. Cantor Fitzgerald reaffirmed a "buy" rating and issued a $162.00 target price on shares of Celgene in a report on Tuesday, September 26th. The firm earned "Equal-Weight" rating on Wednesday, August 17 by Morgan Stanley. Oppenheimer reissued a "buy" rating and issued a $170.00 target price on shares of Celgene in a research report on Friday, October 20th. The firm earned "Outperform" rating on Wednesday, January 20 by Credit Suisse. The rating was maintained by Canaccord Genuity on Tuesday, June 6 with "Buy".
Analysts await Celgene Corporation (NASDAQ:CELG) to report earnings on January, 25. Stifel Nicolaus initiated Celgene Corporation (NASDAQ:CELG) on Friday, July 15 with "Buy" rating.
Investors sentiment decreased to 1.17 in 2017 Q3. Its down 0.16, from 1.16 in 2017Q2. Old Mutual Glob Invsts (Uk) invested in 328,697 shares. 69 funds opened positions while 264 raised stakes. Royal Commercial Bank Of Canada accumulated 2,628 shares. 586.69 million shares or 2.23% less from 600.08 million shares in 2017Q2 were reported. LSV Asset Management purchased a new stake in shares of Celgene in the 2nd quarter valued at approximately $1,701,000. (NYSE:TWX). P Schoenfeld Asset Ltd Partnership has invested 9.9% in Time Warner Inc. Amer National Registered Inv Advisor has 0.17% invested in 8×8, Inc. Malaga Cove Capital Limited Liability Company holds 23,177 shares. (NYSE:EGHT) for 24,945 shares. Granahan Mgmt Ma has 1.57M shares. Pointstate Cap Limited Partnership holds 461,900 shares or 0.4% of its portfolio.
Celgene Co. has a 12-month low of $94.55 and a 12-month high of $147.17. The Washington-based Archon Management Limited Liability Com has invested 1.9% in Amber Road, Inc. Warren Averett Asset Lc reported 3,602 shares. The company has a market capitalization of $83,460.00, a price-to-earnings ratio of 25.00, a price-to-earnings-growth ratio of 0.67 and a beta of 1.77. Utd Services Automobile Association reported 608,964 shares.